Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Rubin

Showing results (61-70 of 461) with videos related to

Pageof 47
Sort By:
The American Journal of Surgical Pathology|February 23, 2002
Tissue microarray sampling strategy for prostate cancer biomarker analysisMark A Rubin, Rodney Dunn, Myla Strawderman, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 11, 2002
Spatial receptive field organization of macaque V4 neuronsDaniel A Pollen, Andrzej W Przybyszewski, Mark A Rubin, et al.
BMC Bioinformatics|November 28, 2006
A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarraysFrancesca Demichelis, Paolo Magni, Paolo Piergiorgi, et al.
The American Journal of Surgical Pathology|June 30, 2004
Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?Mark A Rubin, Tarek A Bismar, Sarah Curtis, et al.
BMC Evolutionary Biology|January 25, 2013
Impact of constitutional copy number variants on biological pathway evolutionMaria Poptsova, Samprit Banerjee, Omer Gokcumen, et al.
The Journal of Pathology|June 5, 2013
Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456Christopher E Barbieri, Andrea Sboner, Mark A Rubin, et al.
Archives of Pathology & Laboratory Medicine|July 10, 2007
A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinomaRonald J Cohen, Thomas M Wheeler, Helmut Bonkhoff, et al.
JCO Precision Oncology|October 29, 2021
PARP Inhibition in Prostate Cancer With Homologous Recombination Repair AlterationsAlexander von Werdt, Laura Brandt, Orlando D Schärer, et al.
Surgical Pathology Clinics|November 7, 2022
Molecular Genetics of Prostate Cancer and Role of Genomic TestingDilara Akhoundova, Felix Y Feng, Colin C Pritchard, et al.
The American Journal of Surgical Pathology|September 10, 2002
Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancerRajal B Shah, Ming Zhou, Michele LeBlanc, et al.
Pageof 47

Showing results (61-70 of 461) with videos related to

Sort By:
Pageof 47
The American Journal of Surgical Pathology|February 23, 2002
Tissue microarray sampling strategy for prostate cancer biomarker analysisMark A Rubin, Rodney Dunn, Myla Strawderman, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 11, 2002
Spatial receptive field organization of macaque V4 neuronsDaniel A Pollen, Andrzej W Przybyszewski, Mark A Rubin, et al.
BMC Bioinformatics|November 28, 2006
A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarraysFrancesca Demichelis, Paolo Magni, Paolo Piergiorgi, et al.
The American Journal of Surgical Pathology|June 30, 2004
Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?Mark A Rubin, Tarek A Bismar, Sarah Curtis, et al.
BMC Evolutionary Biology|January 25, 2013
Impact of constitutional copy number variants on biological pathway evolutionMaria Poptsova, Samprit Banerjee, Omer Gokcumen, et al.
The Journal of Pathology|June 5, 2013
Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456Christopher E Barbieri, Andrea Sboner, Mark A Rubin, et al.
Archives of Pathology & Laboratory Medicine|July 10, 2007
A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinomaRonald J Cohen, Thomas M Wheeler, Helmut Bonkhoff, et al.
JCO Precision Oncology|October 29, 2021
PARP Inhibition in Prostate Cancer With Homologous Recombination Repair AlterationsAlexander von Werdt, Laura Brandt, Orlando D Schärer, et al.
Surgical Pathology Clinics|November 7, 2022
Molecular Genetics of Prostate Cancer and Role of Genomic TestingDilara Akhoundova, Felix Y Feng, Colin C Pritchard, et al.
The American Journal of Surgical Pathology|September 10, 2002
Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancerRajal B Shah, Ming Zhou, Michele LeBlanc, et al.
Pageof 47